Mouse models of diabetes associated with extreme beta-cell loss have demonstrated that reprogramming occurs in around 2% of islet alpha-cells to allow transdifferentiation to beta-cells, with an intermediate cell phenotype of both glucagon and insulin expression [8]. This evidence concerns the gene INS and diabetes mellitus.